Bruker's Revenue in the fiscal year 2025 $ 3,435.70 millions
Bruker's Revenue in the fiscal year 2024 $ 0.00 millions
Bruker's Revenue in the fiscal year 2023 $ 0.00 millions
Bruker's Revenue in the fiscal year 2022 $ 2,530.70 millions
Bruker's Revenue in the fiscal year 2021 $ 2,417.90 millions
BRKR Revenue second quarter 2026 Y/Y Growth Comment
Bruker Corporation reported Revenue growth of 5.22% year on year in the second quarter 2026, to $ 838.50 millions, this is lower than Bruker Corporation's recent average Revenue growth of 6.52%.
Looking into second quarter 2026 results within Laboratory Analytical Instruments industry 11 other companies have achieved higher Revenue growth. While Bruker Corporation' s Revenue increase of 5.22% ranks overall at the positon no. 2366 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Bruker's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
34.14 %
2.77 %
-30.41 %
(Dec 31 2010)
BRKR's II. Quarter Q/Q Revenue Comment
Bruker Corporation achieved in the II. Quarter 2026 below company average Revenue growth of 1.91% quarter on quarter, to $ 838.50 millions.
Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the -0.54% growth in the II. Quarter a year ago
Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Bruker's Revenue growth quarter on quarter, overall rank is 1499.
Bruker Corporation achieved in the II. Quarter 2026 below company average Revenue growth of 1.91% quarter on quarter, to $ 838.50 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -0.54% in the II. Quarter a year ago.
Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Bruker's Revenue growth quarter on quarter, overall rank is 1499.
Bruker's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 3,498.90
$ 3,457.30
$ 3,435.70
$ 3,438.10
$ 3,441.50
Y / Y Revenue Growth (TTM)
1.67 %
0.35 %
2.11 %
6.12 %
10.35 %
Year on Year Revenue Growth Overall
Ranking
# 1124
# 1107
# 0
# 0
# 0
Seqeuential Revenue Change (TTM)
1.2 %
0.63 %
-0.07 %
-0.1 %
-0.11 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2366
# 2044
# 0
# 0
# 0
Cumulative Revenue growth Comment
Although Bruker's Annual Revenue growth year on year were below company's average 6.52% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.67% year on year, from 0.35% in Mar 31 2026.
In the Healthcare sector 206 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1107 to 1124.
Although Bruker's Annual Revenue growth year on year were below company's average 6.52% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.67% year on year, from 0.35% in Mar 31 2026.
In the Healthcare sector 206 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1107 to 1124.
About Bruker Revenue Growth Rates (BRKR), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
9.08%